Johanna Hynninen
Adjunct professor, MD, Gynecologic oncologist
mijohy@utu.fi ORCID identifier: https://orcid.org/0000-0002-0854-7225 |
Areas of expertise
gynaecologic oncology; ovarian cancer
gynaecologic oncology; ovarian cancer
Research community or research topic
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
Publications
- Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma (2023)
- Cancer Cell
(A1 Refereed original research article in a scientific journal) - Evolutionary study identifies poor prognosis HGSC patients and reveals clinically relevant targets at diagnosis and relapse (2023)
- International Journal of Gynecological Cancer
(Other publication) - Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes (2023)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal) - H&E image analysis pipeline for quantifying morphological features (2023)
- Journal of Pathology Informatics
(A1 Refereed original research article in a scientific journal) - Multi-omics characterization of chemo-refractory high-grade serous cancer (2023)
- International Journal of Gynecological Cancer
(Other publication) - Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis (2023)
- STAR protocols
(A1 Refereed original research article in a scientific journal) - Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer (2023)
- Basic and Clinical Pharmacology and Toxicology
(A1 Refereed original research article in a scientific journal) - A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer (2022)
- Cancers
(A1 Refereed original research article in a scientific journal) - Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status (2022)
- Frontiers in Oncology
(A1 Refereed original research article in a scientific journal) - Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer (2022)
- Science Advances
(A1 Refereed original research article in a scientific journal) - Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer (2022)
- npj Precision Oncology
(A1 Refereed original research article in a scientific journal) - QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability (2022)
- Laboratory Investigation
(A1 Refereed original research article in a scientific journal) - Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality (2021)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Agile Workflow For Interactive Analysis Of Mass Cytometry Data (2021)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer (2021)
- Cancers
(A1 Refereed original research article in a scientific journal) - Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance (2021)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer (2021)
- Cancer Imaging
(A1 Refereed original research article in a scientific journal) - FUNGI: Fusion Gene Integration Toolset (2021)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy (2021)
- Cancer Discovery
(A1 Refereed original research article in a scientific journal) - Imaging of Tumor Hypoxia With F-18-EF5 PET/MRI in Cervical Cancer (2021)
- Clinical Nuclear Medicine
(A1 Refereed original research article in a scientific journal)